Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission

References

• Govoni M, Caporali R. Predicting and managing the progression of structural damage in rheumatoid arthritis: where do we stand? Clin Exp Rheumatol 2012;30:459–63.
   PubMed Web of Science ®Google Scholar
• Welsing PMJ, Van Gestel AM, Swinkels HL, Kiemeney LALM, Van Riel PLCM. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009–17.
   PubMed Web of Science ®Google Scholar
• Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum 2004;50:2072–81.
   PubMed Web of Science ®Google Scholar
• Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263–9.
   PubMed Web of Science ®Google Scholar
• Klarenbeek NB, Güler-Yüksel M, Van Der Kooij SM, Han KH, Ronday HK, Kerstens PJSM, et al. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study. Ann Rheum Dis 2011;70:1039–46.
   PubMed Web of Science ®Google Scholar
• Vermeer M, Kuper HH, Moens HJB, Drossaers-Bakker KW, Van Der Bijl AE, Van Riel PLCM, et al. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort. Arthritis Care Res (Hoboken) 2013;65:1219–26.
   PubMed Web of Science ®Google Scholar
• Schipper LG, Vermeer M, Kuper HH, Hoekstra MO, Haagsma CJ, Den Broeder AA, et al. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry. Ann Rheum Dis 2012;71:845–50.
   PubMed Web of Science ®Google Scholar
• Cohen G, Gossec L, Dougados M, Cantagrel A, Goupille P, Daures JP, et al. Radiological damage in patients with rheumatoid arthritis on sustained remission. Ann Rheum Dis 2007;66:358–63.
   PubMed Web of Science ®Google Scholar
• Molenaar ETH, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BAC. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 2004;50:36–42.
   PubMed Web of Science ®Google Scholar
• Van Den Broek M, Dirven L, De Vries-bouwstra JK, Dehpoor AJ, Goekoop-Ruiterman YPM, Gerards AH, et al. Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up. Ann Rheum Dis 2012;71:1530–3.
   PubMed Web of Science ®Google Scholar
• Akdemir G, Verheul MK, Heimans L, Wevers-De Boer KVC, Goekoop-Ruiterman YPM, Van Oosterhout M, et al. Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study. RMD Open 2016;2:1–9.
   Web of Science ®Google Scholar
• De Rooy DPC, Van Der Linden MPM, Knevel R, Huizinga TWJ, Van Der Helm-van AHM. Predicting arthritis outcomes – what can be learned from the Leiden Early Arthritis Clinic? Rheumatology 2011;50:93–100.
   PubMed Web of Science ®Google Scholar
• Visser K, Goekoop-Ruiterman YPM, De Vries-Bouwstra JK, Ronday HK, Seys PEH, Kerstens PJSM, et al. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. Ann Rheum Dis 2010;69:1333–7.
   PubMed Web of Science ®Google Scholar
• Fautrel B, Granger B, Combe B, Saraux A, Guillemin F, Le Loet X. Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort. Arthritis Res Ther 2012;14:R249.
   PubMed Web of Science ®Google Scholar
• Hetland ML, Østergaard M, Stengaard-Pedersen K, Junker P, Ejbjerg B, Jacobsen S, et al. Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years’ functional and radiographic outcome in early rheumatoid arthritis. Scand J Rheumatol 2019;48:1–8.
   PubMed Web of Science ®Google Scholar
• Ziegelasch M, Boman A, Martinsson K, Thyberg I, Jacobs C, Nyhäll-Wåhlin BM, et al. Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006–2011. Scand J Rheumatol 2020;49:434–42.
   PubMed Web of Science ®Google Scholar
• Rydell E, Forslind K, Nilsson J-Å, Jacobsson LTH, Turesson C. Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis. Arthritis Res Ther 2018;20:20.
   PubMed Web of Science ®Google Scholar
• Heimans L, Boer KVCW, Ronday HK, Collée G, De Sonnaville PBJ, Grillet BAM, et al. Can we prevent rapid radiological progression in patients with early rheumatoid arthritis? Clin Rheumatol 2015;34:163–6.
   PubMed Web of Science ®Google Scholar
• Steunebrink LMM, Versteeg LGA, Vonkeman HE, Klooster PM, Hoekstra M, Van De Laar MAFJ. Radiographic progression in early rheumatoid arthritis patients following initial combination versus step-up treat-to- target therapy in daily clinical practice: results from the DREAM registry. BMC Rheumatol 2018;2:1.
   PubMedGoogle Scholar
• Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HLM, et al. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study. Arthritis Rheum 2011;63:2865–72.
   PubMed Web of Science ®Google Scholar
• Prevoo MLL, Van’T Hof MA, Kuper HH, Van Leeuwen MA, Van De Putte LBA, Van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
   PubMed Web of Science ®Google Scholar
• Van Der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261–3.
   PubMed Web of Science ®Google Scholar
• Bruynesteyn K, Boers M, Kostense P, Van Der Linden S, Van Der Heijde D. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis 2005;64:179–82.
   PubMed Web of Science ®Google Scholar
• Van Der Heijde D, Van Der Helm-van Mil AHM, Aletaha D, Bingham CO, Burmester GR, Dougados M, et al. EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria. Ann Rheum Dis 2013;72:479–81.
   PubMed Web of Science ®Google Scholar
• Landewé R, Van Der Heijde D. Radiographic progression depicted by probability plots: presenting data with optimal use of individual values. Arthritis Rheum 2004;50:699–706.
   PubMed Web of Science ®Google Scholar
• Park GS, Wong WK, Khanna D, Gold RH, Paulus HE. Examining radiographic outcomes over time. Rheumatol Int 2014;34:271–9.
   PubMed Web of Science ®Google Scholar
• Versteeg GA, Steunebrink LMM, Vonkeman HE, Ten Klooster PM, Van Der Bijl AE, Van De Laar MAFJ. Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice. Clin Rheumatol 2018;37:1189–97.
   PubMed Web of Science ®Google Scholar
• Sokka T, Kautiainen H, Häkkinen A, Hannonen P. Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years. J Rheumatol 2004;31:1073–82.
   PubMed Web of Science ®Google Scholar
• Carpenter L, Nikiphorou E, Sharpe R, Norton S, Rennie K, Bunn F, et al. Have radiographic progression rates in early rheumatoid arthritis changed? A systematic review and meta-analysis of long-term cohorts. Rheumatology (Oxford) 2016;55:1053–65.
   PubMed Web of Science ®Google Scholar
• Carpenter L, Norton S, Nikiphorou E, Jayakumar K, McWilliams DF, Rennie KL, et al. Reductions in radiographic progression in early rheumatoid arthritis over twenty-five years: changing contribution from rheumatoid factor in two multicenter UK inception cohorts. Arthritis Care Res 2017;69:1809–17.
   Web of Science ®Google Scholar
• Tiippana-Kinnunen T, Laasonen L, Kautiainen H, Paimela L, Leirisalo-Repo M. Impact of early radiographic remission on the 15-year radiographic outcome in patients with rheumatoid arthritis. Scand J Rheumatol 2011;40:263–8.
   PubMed Web of Science ®Google Scholar
• Fedele AL, Petricca L, Tolusso B, Alivernini S, Canestri S, Di Mario C, et al. Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy. Scand J Rheumatol 2018;47:351–9.
   PubMed Web of Science ®Google Scholar
• Krol A, Garred P, Heegaard NHH, Christensen AF, Hetland ML, Stengaard-Pedersen K, et al. Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis. Scand J Rheumatol 2015;44:8–12.
   PubMed Web of Science ®Google Scholar
• Vastesaeger N, Xu S, Aletaha D, Clair EWS, Smolen JS. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. Rheumatology 2009;48:1114–21.
   PubMed Web of Science ®Google Scholar
• Brahe CH, Østergaard M, Johansen JS, Defranoux N, Wang X, Bolce R, et al. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial. Scand J Rheumatol 2019;48:9–16.
   PubMed Web of Science ®Google Scholar
• Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank SE, Sasso EH, Chernoff D, et al. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial. Ann Rheum Dis 2015;74:1102–9.
   PubMed Web of Science ®Google Scholar
• Vermeer M, Kuper HH, Bernelot Moens HJ, Hoekstra M, Posthumus MD, Van Riel PLCM, et al. Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort. Arthritis Res Ther 2012;14:R254.
   PubMed Web of Science ®Google Scholar
• Bruynesteyn K, Van Der Heijde D, Boers M, Saudan A, Peloso P, Paulus H, et al. Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum 2002;46:913–20.
   PubMed Web of Science ®Google Scholar
• Van Den Bemt BJF, Zwikker HE, Van Den Ende CHM. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol 2012;8:337–51.
   PubMed Web of Science ®Google Scholar